Home > Insider Trading > Filing (0001181431-12-007244)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1325879	Aveo Pharmaceuticals Inc	AVEO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1079537	S Raju Kucherlapati	C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-08-30	14,142	$0.00	59,653	No	4	J	Direct
Common Stock	Disposition	2010-08-30	14,142	$0.00	35,858	No	4	J	Indirect	Held by Raju Kucherlapati Grantor Retained Annuity Trust No. 1
Common Stock	Acquisiton	2011-03-15	15,000	$14.44	74,653	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	J	Indirect	Held by Raju Kucherlapati Grantor Retained Annuity Trust No. 1
No	4	P	Direct

Footnotes

The increase of shares of directly held common stock was due to a distribution from the Raju Kucherlapti Grantor Retained Annuity Trust No.1 to the reporting person on 08/30/2010. This transaction was not reported on the reporting person's original Form 4.
The decrease of shares of indirectly held common stock was due to a distribution from the Raju Kucherlapti Grantor Retained Annuity Trust No.1 to the reporting person on 08/30/2010. This transaction was not reported on the reporting person's original Form 4.
Held by the Raju Kucherlapati Grantor Retained Annuity Trust No.1, of which the reporting person is the trustee and exercises sole voting and investment power over the shares of record. The reporting person disclaims beneficial ownership over all such shares, except to the extent of his pecuniary interest therein.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.01 to $14.85, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
The number of shares was incorrectly reported on the reporting person's original Form 4 filed on 03/16/2011.